Medios AG (OTCMKTS:MEDOF) Shares Shorted: Short Interest Up 1,200.0% in September

Medios AG (OTCMKTS:MEDOF) was the target of a significant growth in short interest during the month of September. As of September 30th, there was short interest totaling 858 shares, a growth of 1,200.0% from the September 15th total of 66 shares. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Medios Price Performance

Shares of MEDOF stock remained flat at C$13.64 on Friday. The company’s 50 day moving average is C$13.64 and its two-hundred day moving average is C$13.64. Medios has a twelve month low of C$13.64 and a twelve month high of C$13.64.

Analysts Set New Price Targets

Separately, Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Medios in a research report on Thursday, August 13th. One research analyst has rated the stock with a Buy rating. Based on data from MarketBeat.com, the stock has an average rating of “Buy”.

Medios Company Profile

Medios AG is a Germany-based specialty pharmaceutical company that supplies medicines and related services for patients with complex, chronic and rare diseases. The company works primarily with pharmacies, medical providers and other healthcare partners, supporting the delivery of therapies that often require specialized handling and coordination.

Its activities include the pharmaceutical supply of specialty medicines and the preparation of patient-specific therapies. Medios focuses on areas such as oncology, autoimmune diseases, neurology and other conditions in which individualized treatment solutions or close pharmaceutical support may be required.

Based in Berlin, Medios serves the German healthcare market through its specialty pharmaceutical platform and pharmacy network.